These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

350 related articles for article (PubMed ID: 18034952)

  • 21. Pulmonary resection combined with isoniazid- and rifampin-based drug therapy for patients with multidrug-resistant and extensively drug-resistant tuberculosis.
    Park SK; Kim JH; Kang H; Cho JS; Smego RA
    Int J Infect Dis; 2009 Mar; 13(2):170-5. PubMed ID: 18768342
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Risk factors associated with default from multidrug-resistant tuberculosis treatment, South Africa, 1999-2001.
    Holtz TH; Lancaster J; Laserson KF; Wells CD; Thorpe L; Weyer K
    Int J Tuberc Lung Dis; 2006 Jun; 10(6):649-55. PubMed ID: 16776452
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Representative drug susceptibility patterns for guiding design of re-treatment regimens for multidrug-resistant tuberculosis in Iran.
    Tabarsi P; Nooraki A; Mirsaeidi M; Amiri M; Baghaei P; Farnia P; Kazempour M; Heidarnazhad H; Alipanah N; Mansouri D; Masjedi MR
    Respirology; 2008 Jan; 13(1):108-11. PubMed ID: 18197919
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Alcohol use and the management of multidrug-resistant tuberculosis in Tomsk, Russian Federation.
    Miller AC; Gelmanova IY; Keshavjee S; Atwood S; Yanova G; Mishustin S; Furin JJ; Shin SS
    Int J Tuberc Lung Dis; 2012 Jul; 16(7):891-6. PubMed ID: 22507895
    [TBL] [Abstract][Full Text] [Related]  

  • 25. HIV coinfection among multidrug resistant and extensively drug resistant tuberculosis patients--a trend.
    Rajasekaran S; Chandrasekar C; Mahilmaran A; Kanakaraj K; Karthikeyan DS; Suriakumar J
    J Indian Med Assoc; 2009 May; 107(5):281-2, 284-6. PubMed ID: 19886382
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cost and cost-effectiveness of multidrug-resistant tuberculosis treatment in Estonia and Russia.
    Floyd K; Hutubessy R; Kliiman K; Centis R; Khurieva N; Jakobowiak W; Danilovits M; Peremitin G; Keshavjee S; Migliori GB
    Eur Respir J; 2012 Jul; 40(1):133-42. PubMed ID: 22362862
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Standardised second-line treatment of multidrug-resistant tuberculosis during pregnancy.
    Tabarsi P; Moradi A; Baghaei P; Marjani M; Shamaei M; Mansouri N; Chitsaz E; Farnia P; Mansouri D; Masjedi M; Velayati A
    Int J Tuberc Lung Dis; 2011 Apr; 15(4):547-50. PubMed ID: 21396217
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In vitro drug resistance and response to therapy in pulmonary tuberculosis patients under a DOTS programme in south India.
    Aparna SB; Reddy VC; Gokhale S; Moorthy KV
    Trans R Soc Trop Med Hyg; 2009 Jun; 103(6):564-70. PubMed ID: 19243801
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tuberculosis retreatment category predicts resistance in hospitalized retreatment patients in a high HIV prevalence area.
    Schreiber YS; Herrera AF; Wilson D; Wallengren K; Draper R; Muller J; Dawood H; Doucette S; Cameron DW; Alvarez GG
    Int J Tuberc Lung Dis; 2009 Oct; 13(10):1274-80. PubMed ID: 19793433
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Treatment interruptions and duration associated with default among new patients with tuberculosis in six regions of Russia.
    Jakubowiak W; Bogorodskaya E; Borisov S; Danilova I; Kourbatova E
    Int J Infect Dis; 2009 May; 13(3):362-8. PubMed ID: 19008141
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Risk factors for multidrug-resistant tuberculosis in four centers in Burkina Faso, West Africa.
    Diandé S; Sangaré L; Kouanda S; Dingtoumda BI; Mourfou A; Ouédraogo F; Sawadogo I; Nébié B; Gueye A; Sawadogo LT; Traoré AS
    Microb Drug Resist; 2009 Sep; 15(3):217-21. PubMed ID: 19728781
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Risk factors for drug resistant tuberculosis in southeast Turkey.
    Tanrikulu AC; Hosoglu S; Ozekinci T; Abakay A; Gurkan F
    Trop Doct; 2008 Apr; 38(2):91-3. PubMed ID: 18453496
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Two simultaneous outbreaks of multidrug-resistant tuberculosis--Federated States of Micronesia, 2007-2009.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2009 Mar; 58(10):253-6. PubMed ID: 19300407
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Putting in harm to cure: Drug related adverse events do not affect outcome of patients receiving treatment for multidrug-resistant Tuberculosis. Experience from a tertiary hospital in Italy.
    Gualano G; Mencarini P; Musso M; Mosti S; Santangelo L; Murachelli S; Cannas A; Di Caro A; Navarra A; Goletti D; Girardi E; Palmieri F
    PLoS One; 2019; 14(2):e0212948. PubMed ID: 30817779
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Clinical research on multi-drug resistant and extensive drug-resistant tuberculosis in Japan].
    Toyota E; Kawabe Y; Yotsumoto H; Sakatani M; Tsuyuguchi K; Maekura R; Fujikawa K; Takashima T; Ogawa K; Yoshiyama T; Sugie T
    Kekkaku; 2008 Dec; 83(12):773-7. PubMed ID: 19172822
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [A-cohort study on the standard short-course chemotherapy program for drug resistant tuberculosis in the rural counties in Eastern China].
    Hu Y; Jiang WL; Wang WB; Xu B
    Zhonghua Liu Xing Bing Xue Za Zhi; 2008 Jun; 29(6):540-4. PubMed ID: 19040032
    [TBL] [Abstract][Full Text] [Related]  

  • 37. High rate of hypothyroidism among patients treated for multidrug-resistant tuberculosis in Lesotho.
    Satti H; Mafukidze A; Jooste PL; McLaughlin MM; Farmer PE; Seung KJ
    Int J Tuberc Lung Dis; 2012 Apr; 16(4):468-72. PubMed ID: 22326109
    [TBL] [Abstract][Full Text] [Related]  

  • 38. An intervention programme for the management of multidrug-resistant tuberculosis in France.
    Uffredi ML; Truffot-Pernot C; Dautzenberg B; Renard M; Jarlier V; Robert J
    Int J Antimicrob Agents; 2007 Apr; 29(4):434-9. PubMed ID: 17300920
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Multidrug resistant tuberculosis in Iceland--case series and review of the literature].
    Asgeirsson H; Blöndal K; Blöndal T; Gottfredsson M
    Laeknabladid; 2009; 95(7-8):499-507. PubMed ID: 19553708
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Seven-year DOTS-Plus pilot experience in India: results, constraints and issues.
    Singla R; Sarin R; Khalid UK; Mathuria K; Singla N; Jaiswal A; Puri MM; Visalakshi P; Behera D
    Int J Tuberc Lung Dis; 2009 Aug; 13(8):976-81. PubMed ID: 19723377
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.